Symbiosis Pharmaceutical Services, an international contract manufacturing organization (CMO) with headquarters in the UK, who specialize in providing GMP aseptic fill and finish services for biologic and small molecule pharmaceuticals to biotechnology and pharmaceutical companies worldwide, has announced a $1.3 million investment in its in-house analytical services capabilities.
Symbiosis Pharmaceutical Services, a contract manufacturing organization (CMO) specializing in sterile global manufacture of pharmaceuticals, vaccines and biopharmaceuticals including Advanced Therapeutical Medicinal Products (ATMPs), has completed a £1.3 million collaborative UK Research and Innovation Project (UKRI)-funded project as part of the medicines manufacturing challenge.
Symbiosis Pharmaceutical Services, a contract manufacturing organization ( CMO ) specializing in sterile manufacture of vaccines, pharmaceuticals and biopharmaceuticals, has expanded its capabilities to handle novel and emerging treatments, such as viral based gene - and oncolytic-therapies.
More than two years after PlateletBio landed its first round of fundraising and a contract with the US government, the company announced its Series B round Thursday.
BENTONVILLE, Ark.--(BUSINESS WIRE)--SymBiosis Capital Management, LLC (“SymBiosis”) today announced its launch as a newly independent venture capital firm focused on advancing biotherapeutics innovations. Investing since 2019, SymBiosis has received significant, long-term capital commitments to actively support its current portfolio of more than 20 investments and fund future investments.
Modus Therapeutics, a company developing pharmaceutical therapies for diseases with high unmet medical need, has announced that Symbiosis Pharmaceutical Services Ltd has begun manufacturing sevuparin. This secures the supply for the Phase II clinical development in sepsis, and other conditions driven by systematic inflammation.
Symbiosis Pharmaceutical Services, a contract manufacturing organization (CMO) specializing in sterile manufacture of vaccines, pharmaceuticals and biopharmaceuticals, and headquartered in Stirling, UK, has successfully completed a Medicines and Healthcare products Regulatory Agency (MHRA) inspection of its newly commissioned warehouse and storage area.
Symbiosis, AstraZeneca Sign Supply Agreement for Sterile Vaccine Manufacture
(Reuters) - AstraZeneca (AZN.L) has signed its tenth supply-and-manufacturing deal for its experimental COVID-19 vaccine with a Scotland-backed firm as the British drugmaker ramps up efforts for wider trials of the potential treatment.
STIRLING, Scotland, June 24, 2020 /PRNewswire/ -- Symbiosis Pharmaceutical Services, a specialist provider of pharmaceutical and vaccine development services, has announced it has signed a supply agreement with AstraZeneca for sterile manufacture of the COVID-19 recombinant adenovirus vaccine known as AZD1222 for AstraZeneca sponsored clinical trials.